165 related articles for article (PubMed ID: 36233480)
1. Analysis of Sphingolipids in Pediatric Patients with Cholelithiasis-A Preliminary Study.
Zdanowicz K; Bobrus-Chcociej A; Pogodzinska K; Blachnio-Zabielska A; Zelazowska-Rutkowska B; Lebensztejn DM; Daniluk U
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233480
[TBL] [Abstract][Full Text] [Related]
2. Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children.
Filimoniuk A; Blachnio-Zabielska A; Imierska M; Lebensztejn DM; Daniluk U
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708181
[TBL] [Abstract][Full Text] [Related]
3. Diverse Sphingolipid Profiles in Rectal and Colon Cancer.
Markowski AR; Błachnio-Zabielska AU; Pogodzińska K; Markowska AJ; Zabielski P
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446046
[TBL] [Abstract][Full Text] [Related]
4. Serum C18:1-Cer as a Potential Biomarker for Early Detection of Gestational Diabetes.
Juchnicka I; Kuźmicki M; Zabielski P; Krętowski A; Błachnio-Zabielska A; Szamatowicz J
J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054078
[TBL] [Abstract][Full Text] [Related]
5. Blood bioactive sphingolipids in patients with advanced serous epithelial ovarian cancer - mass spectrometry analysis.
Knapp P; Bodnar L; Błachnio-Zabielska A; Reszeć J; Świderska M; Chabowski A
Arch Med Sci; 2021; 17(1):53-61. PubMed ID: 33488856
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipidomic profile and HDL subfractions in obese dyslipidemic type 2 diabetic patients.
Aslan İ; Aydın D; Koca Y; Yılmaz Ç; Çeker T; Öztüzün A; Aslan M
Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106719. PubMed ID: 36863606
[TBL] [Abstract][Full Text] [Related]
7. Serum Sphingolipidomic Analysis in Acne Vulgaris Patients.
Kaya S; Aslan İ; Kıraç E; Karaarslan T; Aslan M
Ann Clin Lab Sci; 2019 Mar; 49(2):242-248. PubMed ID: 31028071
[TBL] [Abstract][Full Text] [Related]
8. Plasma and ovarian tissue sphingolipids profiling in patients with advanced ovarian cancer.
Knapp P; Bodnar L; Błachnio-Zabielska A; Świderska M; Chabowski A
Gynecol Oncol; 2017 Oct; 147(1):139-144. PubMed ID: 28800942
[TBL] [Abstract][Full Text] [Related]
9. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients.
Aslan M; Kıraç E; Kaya S; Özcan F; Salim O; Küpesiz OA
Lipids; 2018 Mar; 53(3):313-322. PubMed ID: 29663386
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a "Biochemical" Diagnosis of Metabolic Syndrome?
Rigamonti AE; Dei Cas M; Caroli D; De Col A; Cella SG; Paroni R; Sartorio A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108620
[TBL] [Abstract][Full Text] [Related]
11. Maternal plasma and amniotic fluid sphingolipids profiling in fetal Down syndrome.
Charkiewicz K; Blachnio-Zabielska A; Zbucka-Kretowska M; Wolczynski S; Laudanski P
PLoS One; 2015; 10(5):e0127732. PubMed ID: 26000716
[TBL] [Abstract][Full Text] [Related]
12. Ceramide metabolism mediates the impaired glucose homeostasis following short-term black carbon exposure: A targeted lipidomic analysis.
Xu Y; Chen X; Han Y; Chen W; Wang T; Gong J; Fan Y; Zhang H; Zhang L; Li H; Wang Q; Yao Y; Xue T; Wang J; Qiu X; Que C; Zheng M; Zhu T
Sci Total Environ; 2022 Jul; 829():154657. PubMed ID: 35314239
[TBL] [Abstract][Full Text] [Related]
13. Sphingomyelin profiling in patients with diabetes could be potentially useful as differential diagnostics biomarker: A pilot study.
Sokołowska E; Car H; Fiedorowicz A; Szelachowska M; Milewska A; Wawrusiewicz-Kurylonek N; Szumowski P; Krzyżanowska-Grycel E; Popławska-Kita A; Żendzian-Piotrowska M; Chabowski A; Krętowski A; Siewko K
Adv Med Sci; 2022 Sep; 67(2):250-256. PubMed ID: 35785598
[TBL] [Abstract][Full Text] [Related]
14. Ramadan intermittent fasting is associated with ameliorated inflammatory markers and improved plasma sphingolipids/ceramides in subjects with obesity: lipidomics analysis.
Madkour MI; Islam MT; Tippetts TS; Chowdhury KH; Lesniewski LA; Summers SA; Zeb F; Abdelrahim DN; AlKurd R; Khraiwesh HM; AbuShihab KH; AlBakri A; Obaideen K; Faris ME
Sci Rep; 2023 Oct; 13(1):17322. PubMed ID: 37833312
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipids as a new factor in the pathomechanism of preeclampsia - Mass spectrometry analysis.
Charkiewicz K; Goscik J; Blachnio-Zabielska A; Raba G; Sakowicz A; Kalinka J; Chabowski A; Laudanski P
PLoS One; 2017; 12(5):e0177601. PubMed ID: 28542236
[TBL] [Abstract][Full Text] [Related]
16. Ceramides and sphingosine-1-phosphate as potential markers in diagnosis of ischaemic stroke.
Fiedorowicz A; Kozak-Sykała A; Bobak Ł; Kałas W; Strządała L
Neurol Neurochir Pol; 2019; 53(6):484-491. PubMed ID: 31804702
[TBL] [Abstract][Full Text] [Related]
17. Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance.
Blachnio-Zabielska AU; Koutsari C; Tchkonia T; Jensen MD
Obesity (Silver Spring); 2012 Dec; 20(12):2341-7. PubMed ID: 22677645
[TBL] [Abstract][Full Text] [Related]
18. Blood sphingolipidomics in healthy humans: impact of sample collection methodology.
Hammad SM; Pierce JS; Soodavar F; Smith KJ; Al Gadban MM; Rembiesa B; Klein RL; Hannun YA; Bielawski J; Bielawska A
J Lipid Res; 2010 Oct; 51(10):3074-87. PubMed ID: 20660127
[TBL] [Abstract][Full Text] [Related]
19. Sphingomyelins and ceramides: possible biomarkers for dementia?
Loft LMI; Moseholm KF; Pedersen KKW; Jensen MK; Koch M; Cronjé HT
Curr Opin Lipidol; 2022 Feb; 33(1):57-67. PubMed ID: 34879042
[TBL] [Abstract][Full Text] [Related]
20. The relevance of ceramides and their synthesizing enzymes for multiple sclerosis.
Kurz J; Brunkhorst R; Foerch C; Blum L; Henke M; Gabriel L; Ulshöfer T; Ferreirós N; Parnham MJ; Geisslinger G; Schiffmann S
Clin Sci (Lond); 2018 Sep; 132(17):1963-1976. PubMed ID: 30219773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
